Hanwha Q Cells Co. Ltd. (NASDAQ:HQCL)‘s stock had its “neutral” rating reiterated by investment analysts at Roth Capital in a report released on Monday. They presently have a $10.00 price target on the stock, down from their previous price target of $13.00. Roth Capital’s price objective points to a potential upside of 13.25% from the stock’s previous close.
Separately, Zacks Investment Research downgraded Hanwha Q Cells Co. from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 9th.
Shares of Hanwha Q Cells Co. (NASDAQ:HQCL) traded down 6.09% during mid-day trading on Monday, reaching $8.79. The company’s stock had a trading volume of 35,256 shares. Hanwha Q Cells Co. has a 52-week low of $8.74 and a 52-week high of $9.45. The company has a 50-day moving average price of $0.00 and a 200 day moving average price of $0.00.
Hanwha Q Cells Co. (NASDAQ:HQCL) last posted its quarterly earnings data on Tuesday, November 22nd. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.21 by $0.29. Hanwha Q Cells Co. had a return on equity of 42.02% and a net margin of 6.73%. The firm had revenue of $707.80 million for the quarter, compared to the consensus estimate of $653.40 million. The company’s revenue for the quarter was up 65.7% compared to the same quarter last year. Analysts forecast that Hanwha Q Cells Co. will post $1.67 earnings per share for the current fiscal year.
A number of hedge funds have recently modified their holdings of HQCL. Walleye Trading LLC increased its stake in shares of Hanwha Q Cells Co. by 1,166.7% in the second quarter. Walleye Trading LLC now owns 7,600 shares of the company’s stock valued at $109,000 after buying an additional 7,000 shares during the period. AJO LP purchased a new position in Hanwha Q Cells Co. during the second quarter valued at $171,000. KBC Group NV boosted its position in Hanwha Q Cells Co. by 36.3% in the third quarter. KBC Group NV now owns 17,098 shares of the company’s stock valued at $192,000 after buying an additional 4,554 shares in the last quarter. Oxford Asset Management purchased a new position in Hanwha Q Cells Co. during the second quarter valued at $392,000. Finally, Barclays PLC purchased a new position in Hanwha Q Cells Co. during the first quarter valued at $432,000. 1.29% of the stock is currently owned by institutional investors.
Hanwha Q Cells Co. Company Profile